MedPath

Irregular and scanty menses improvement with Lashun Kalk in Artavkshay with special reference to Oligohypomenorrhea.

Phase 2
Completed
Conditions
Health Condition 1: N915- Oligomenorrhea, unspecified
Registration Number
CTRI/2022/01/039423
Lead Sponsor
Dr Meenakshi Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
38
Inclusion Criteria

1.Patient fulfilling diagnostic criteria for Artavkshay.

2.Both married and unmarried women.

3.patients between age group 16yrs to 40 yrs

Exclusion Criteria

1.Pregnant and lactating women.

2.k/c/o Thyroid dysfunction,Kochs,DM,HTN,Vascular (bleding)disorder.

3.Hb count <8gm/dl

4.congenital anomalies and malignacy of reproductive System

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of Lashunkalk in the management of Artavkshay with special reference to oligohypomenorrhea.Timepoint: Treatment will be given from 4th day of menses for 30 days for 3 consecutive cycle, follow up after each month
Secondary Outcome Measures
NameTimeMethod
1 To study the complete literature available on Artavkshay. <br/ ><br>2.To observe the effect of Lashun on ovarian hormones. <br/ ><br>3.To propose the safe, cost effective, easily available,palatable an ayurvedic regimen in management of Artavkshay by using Laashun Kalk. <br/ ><br>4.To study side effect if occurs any.Timepoint: Treatment will be given from 4th day of menses for 30 days for 3 consecutive cycle, follow up after each month
© Copyright 2025. All Rights Reserved by MedPath